Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

NCT00685022 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Levalbuterol HFA MDI followed by Racemic albuterol HFA MDI
DRUG: Racemic Albuterol followed by levalbuterol HFA MDI

Sponsor

Sumitomo Pharma America, Inc.